The Effect of Motivational Interviewing on HPV-DNA Testing
The Effect of Health Belief Model-Based Motivational Interviews on Women's HPV-DNA Testing According to the Precautionary Acceptance Process
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Muazez küçükkaya
- Phone Number: 5347002115
- Email: muazezkaya25@hotmail.com
Study Contact Backup
- Name: Esma Demirezen
- Phone Number: 5332578594
- Email: esma.demirezen@iuc.edu.tr
Study Locations
-
-
BAYRAMPAŞA
-
Istanbul, BAYRAMPAŞA, Turkey (Türkiye), 340000
- Bayrampaşa 1 nolu ASM
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Study Population
Description
Inclusion Criteria:
- Women aged 30-45 registered at Family Health Centre No. 1,
- Who currently have or have had an active sex life,
- Women who have not undergone an HPV-DNA test in the last five years,
- Women who can read and write, have no communication problems, and can use a smartphone and WhatsApp,
- Women with no diagnosed psychiatric problems,
- Women who agreed to participate in the study.
Exclusion Criteria:
- Women who were unable to complete the entire study due to any circumstances during the data collection phases,
- Women who voluntarily withdrew from the study were excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Experimental group
Participants in the experimental group will be given motivational interviews about HPV at 4 different times and will also be given an educational brochure.
|
No application will be made to the participants in the control group
|
|
No Intervention: control group
Participants in the control group will not receive any intervention
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Learning about HPV
Time Frame: From the beginning of the study until the 4th month.
|
The program was planned as 4 sessions and the duration of the interview was 20-30 minutes.
The women in the experimental group will be given 4 motivational interviews and a training brochure.
Questionnaire/scale forms will be administered 4 times in total: The scales will be administered as a pre-test before the intervention, an interim test after the second motivational interview, a final test after the fourth motivational interview, and a final test two months after the last interview.
The total score to be obtained from HPV-BÖ is between 0-33 and a high score indicates a high level of knowledge about HPV, HPV screening tests and the HPV vaccine The "Cervical Cancer and Pap-smear Test Health Belief Model Scale" will be used to understand the situations that prevent women from taking the HPV-DNA test.
|
From the beginning of the study until the 4th month.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Having an HPV-DNA test
Time Frame: From the beginning of the study until the 4th month.
|
The decision of women in the experimental group to have HPV-DNA testing will be questioned.
|
From the beginning of the study until the 4th month.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Muazez Küçükkaya, Istanbul University - Cerrahpasa
Publications and helpful links
General Publications
- Lewandowska AM, Lewandowski T, Rudzki M, Rudzki S, Laskowska B. Cancer prevention - review paper. Ann Agric Environ Med. 2021 Mar 18;28(1):11-19. doi: 10.26444/aaem/116906. Epub 2020 Mar 12.
- Ghasemi M, Savabi-Esfahani M, Noroozi M, Satari M. Prediction of cervical cancer screening: application of the information-motivation-behavioral skills model. BMC Cancer. 2024 Mar 19;24(1):351. doi: 10.1186/s12885-024-12098-9.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Genital Diseases
- Urogenital Neoplasms
- Neoplasms by Site
- Neoplasms
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Uterine Diseases
- Genital Diseases, Female
- Genital Neoplasms, Female
- Uterine Cervical Diseases
- Uterine Neoplasms
- Uterine Cervical Neoplasms
Other Study ID Numbers
Other Study ID Numbers
- IstanbulUC-SBF-MK-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Study Data/Documents
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.